Table 2.
Antimicrobial susceptibility of the isolates.
| Antimicrobial Class | Antimicrobial Agent | I |
R |
NS (I + R) |
S |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | ||
| Aminoglycosides | Kanamycin | 21 (11.5) | 80 (43.7) | 101 (55.2) | 82 (44.8) |
| Gentamicin | 0 (0) | 45 (24.6) | 45 (24.6) | 138 (75.4) | |
| Amikacin | 11 (6.0) | 21 (11.5) | 32 (17.5) | 151 (82.5) | |
| Tobramycin | 1 (0.5) | 50 (27.3) | 51 (27.9) | 132 (72.1) | |
| Netilmicin | 6 (3.3) | 24 (13.1) | 30 (16.4) | 153 (83.6) | |
| Streptomycin | 11 (6.0) | 61 (33.3) | 72 (39.3) | 111 (60.7) | |
| Quinolones | Ciprofloxacin | 42 (23.0) | 66 (36.1) | 108 (59.0) | 75 (41.0) |
| Levofloxacin | 35 (19.1) | 42 (23.0) | 77 (42.1) | 106 (57.9) | |
| Lomefloxacin | 24 (13.1) | 53 (29.0) | 77 (42.1) | 106 (57.9) | |
| Norfloxacin | 9 (4.9) | 36 (19.7) | 45 (24.6) | 138 (75.4) | |
| Ofloxacin | 2 (1.1) | 41 (22.4) | 43 (23.5) | 140 (76.5) | |
| 4th generation cephalosporin | Cefepime | 12 (6.6) | 77 (42.1) | 89 (48.6) | 94 (51.4) |
| Beta-Lactam and beta-lactamase inhibitor | Amoxicillin-clavulanate | 59 (32.2) | 73 (39.9) | 132 (72.1) | 51 (27.9) |
| Monobactam | Aztreonam | 20 (10.9) | 57 (31.1) | 77 (42.1) | 106 (57.9) |
| 3rd generations cephalosporin | Cefpodoxime | 5 (2.7) | 98 (53.6) | 103 (56.3) | 80 (43.7) |
| Ceftazidime | 32 (17.5) | 51 (27.9) | 83 (45.4) | 100 (54.6) | |
| Ceftriaxone | 3 (1.6) | 87 (47.5) | 90 (49.2) | 93 (50.8) | |
| Cefotaxime | 7 (3.8) | 90 (49.2) | 97 (53.0) | 86 (47.0) |
I: intermediate susceptibility. N: count. NS: non-susceptible. R: resistant. S: susceptible.